Are there any new partnership or licensing agreements disclosed?

Answer: No new partnership or licensing agreements were disclosed in the announcement.

Explanation

• The press release titled “BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update” is focused on scheduling a conference call for August 14, 2025, at 8:30 a.m. Eastern Time.
• The summary explicitly mentions that BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) will discuss its second‑quarter financial results and provide a corporate update during that call.
• The content provided does not include any reference to new collaborations, partnership arrangements, or licensing agreements—either with academic institutions, biotech/pharma companies, or other entities.
• In earnings‑related announcements, companies typically highlight financial performance, operational milestones, and occasionally strategic deals. In this case, the only disclosed information pertains to the timing of the earnings call and the nature of the corporate update, with no mention of additional agreements.

Conclusion

Based on the information given, BrainStorm Cell Therapeutics did not announce any new partnership or licensing agreements in this particular release. If you require details on any agreements that might be discussed during the upcoming earnings call, you would need to listen to the call itself or review the accompanying slide deck/press materials that are typically released alongside the earnings presentation.